Protonstatin-1

CAS No. 521972-99-6

Protonstatin-1( —— )

Catalog No. M36384 CAS No. 521972-99-6

Protonstatin-1 is used as a hypoglycemic agent and as a compound for the treatment of Alzheimer's disease, inhibits IGFIR kinase activity and can be used in cancer research.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 296 Get Quote
5MG 418 Get Quote
10MG 616 Get Quote
25MG 908 Get Quote
50MG 1279 Get Quote
100MG 1683 Get Quote
500MG 3357 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Protonstatin-1
  • Note
    Research use only, not for human use.
  • Brief Description
    Protonstatin-1 is used as a hypoglycemic agent and as a compound for the treatment of Alzheimer's disease, inhibits IGFIR kinase activity and can be used in cancer research.
  • Description
    Protonstatin-1 is used as a hypoglycemic agent and as a compound for the treatment of Alzheimer's disease, inhibits IGFIR kinase activity and can be used in cancer research.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    IGF-1R
  • Recptor
    IGF-1R
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    521972-99-6
  • Formula Weight
    211.26
  • Molecular Formula
    C8H5NO2S2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C1NC(=S)S\C1=C/C1=CC=CO1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Insulin(human)

    Insulin(human) is a polypeptide hormone that regulates the level of glucose.

  • BMS-754807

    BMS-754807 (BMS 754807, BMS754807)?is a potent, reversible, orally active inhibitor of IGF-1R/Insulin receptor with IC50 of 1.8 and 1.7 nM, respectively.

  • NT157

    NT157 is a small molecule tyrphostin targeting IRS protein and has the potential to inhibit IGF-1R and STAT3 signaling pathways in TME cancer cells and stromal cells, resulting in decreased cancer cell survival.